Mandate

Atria submits a compulsory acquisition offer for all shares in AB Sardus

March 09, 2007

Further to acquiring shares representing 57.1 percent of the share capital and voting rights of AB Sardus after full dilution with regard to issued warrants, Atria has submitted a compulsory acquisition offer for the remaining shares in AB Sardus.

Vinge was adviser to the board of directors of AB Sardus. Johan Winnerblad and Rikard Stenberg represented Vinge.

Related

Vinge advises Isofol Medical AB (publ) in connection with its rights issue of units

Through the rights issue of units, consisting of shares and warrants, and the exercised over-allotment issue, Isofol will receive approximately SEK 84 million and may receive an additional maximum of approximately SEK 110 million upon exercise of all warrants at the highest subscription price.
August 01, 2025

Vinge advises Oncorena in connection with share issue

Vinge advises Oncorena Holding AB in connection with a share issue of approximately SEK 133 million.
July 30, 2025

Vinge advises Karl Hedin and minority owners on the sale of AB Karl Hedin Sågverk to Vida

Vinge has advised Karl Hedin and minority shareholders in connection with the sale of AB Karl Hedin Sågverk to Vida Aktiebolag (“Vida”).
July 24, 2025